Literaturliste
Pathologie und histopathologische Prognosefaktoren oraler Karzinome
PD Dr. med. Stephan Schwarz-Furlan
Oralchirurgie Journal 3/2013
1.
Ackerman LV. Verrucous carcinoma of the oral cavity. Surgery 1948;23:670678
2.
Akhter M, Hossain S, Rahman QB, et al. A study on histological grading of oral
squamous cell carcinoma and its co-relationship with regional metastasis. J
Oral Maxillofac Pathol 2011;15:168-176
3.
Al-Rawi NH, Talabani NG. Squamous cell carcinoma of the oral cavity: a case
series analysis of clinical presentation and histological grading of 1,425 cases
from Iraq. Clinical oral investigations 2008;12:15-18
4.
Anneroth G, Hansen LS, Silverman S, Jr. Malignancy grading in oral
squamous cell carcinoma. I. Squamous cell carcinoma of the tongue and floor
of mouth: histologic grading in the clinical evaluation. Journal of oral pathology
1986;15:162-168
5.
Araujo V, Sousa S, Jaeger M, et al. Characterization of the cellular component
of polymorphous low-grade adenocarcinoma by immunohistochemistry and
electron microscopy. Oral Oncol 1999;35:164-172
6.
Arduino PG, Carrozzo M, Chiecchio A, et al. Clinical and histopathologic
independent prognostic factors in oral squamous cell carcinoma: a
retrospective study of 334 cases. J Oral Maxillofac Surg 2008;66:1570-1579
7.
Batsakis JG, Pinkston GR, Luna MA, et al. Adenocarcinomas of the oral
cavity: a clinicopathologic study of terminal duct carcinomas. J Laryngol Otol
1983;97:825-835
8.
Bertolus C, Goudot P, Gessain A, et al. Clinical relevance of systematic
human papillomavirus (HPV) diagnosis in oral squamous cell carcinoma. Infect
Agent Cancer 2012;7:13
9.
Bitu CC, Destro MF, Carrera M, et al. HOXA1 is overexpressed in oral
squamous cell carcinomas and its expression is correlated with poor
prognosis. BMC Cancer 2012;12:146
10.
Bose P, Klimowicz AC, Kornaga E, et al. Bax expression measured by
AQUAnalysis is an independent prognostic marker in oral squamous cell
carcinoma. BMC Cancer 2012;12:332
11.
Braakhuis BJ, Bloemena E, Leemans CR, et al. Molecular analysis of surgical
margins in head and neck cancer: more than a marginal issue. Oral Oncol
2010;46:485-491
12.
Brandwein-Gensler M, Teixeira MS, Lewis CM, et al. Oral squamous cell
carcinoma: histologic risk assessment, but not margin status, is strongly
predictive of local disease-free and overall survival. The American journal of
surgical pathology 2005;29:167-178
13.
Broders AC. Epithelioma of the cavities and internal organs of the head and
neck. Arch Surg 1925;11:43-73
14.
Broders AC. Squamous cell cancer of the lip: a study of five hundred and
thirty-seven cases. Journal of the American Medical Association 1920;74:656664
15.
Bryne M, Koppang HS, Lilleng R, et al. Malignancy grading of the deep
invasive margins of oral squamous cell carcinomas has high prognostic value.
The Journal of pathology 1992;166:375-381
16.
Bryne M, Koppang HS, Lilleng R, et al. New malignancy grading is a better
prognostic indicator than Broders' grading in oral squamous cell carcinomas. J
Oral Pathol Med 1989;18:432-437
17.
Buchner A, Merrell PW, Carpenter WM. Relative frequency of intra-oral minor
salivary gland tumors: a study of 380 cases from northern California and
comparison to reports from other parts of the world. J Oral Pathol Med
2007;36:207-214
18.
Campisi G, Giovannelli L, Calvino F, et al. HPV infection in relation to OSCC
histological grading and TNM stage. Evaluation by traditional statistics and
fuzzy logic model. Oral Oncol 2006;42:638-645
19.
Chernock RD, El-Mofty SK, Thorstad WL, et al. HPV-related nonkeratinizing
squamous cell carcinoma of the oropharynx: utility of microscopic features in
predicting patient outcome. Head and neck pathology 2009;3:186-194
20.
da Cruz Perez DE, de Abreu Alves F, Nobuko Nishimoto I, et al. Prognostic
factors in head and neck adenoid cystic carcinoma. Oral Oncol 2006;42:139146
21.
de Sampaio Goes FC, Oliveira DT, Dorta RG, et al. Prognoses of oral basaloid
squamous cell carcinoma and squamous cell carcinoma: a comparison. Arch
Otolaryngol Head Neck Surg 2004;130:83-86
22.
Dhanuthai K, Boonadulyarat M, Jaengjongdee T, et al. A clinico-pathologic
study of 311 intra-oral salivary gland tumors in Thais. J Oral Pathol Med
2009;38:495-500
23.
Duray A, Descamps G, Decaestecker C, et al. Human papillomavirus DNA
strongly correlates with a poorer prognosis in oral cavity carcinoma.
Laryngoscope 2012;122:1558-1565
24.
Edwards PC, Bhuiya T, Kelsch RD. C-kit expression in the salivary gland
neoplasms adenoid cystic carcinoma, polymorphous low-grade
adenocarcinoma, and monomorphic adenoma. Oral surgery, oral medicine,
oral pathology, oral radiology, and endodontics 2003;95:586-593
25.
Epivatianos A, Poulopoulos A, Dimitrakopoulos I, et al. Application of alphasmooth muscle actin and c-kit in the differential diagnosis of adenoid cystic
carcinoma from polymorphous low-grade adenocarcinoma. Oral Oncol
2007;43:67-76
26.
Ettl T, Schwarz S, Kleinsasser N, et al. Overexpression of EGFR and absence
of C-KIT expression correlate with poor prognosis in salivary gland
carcinomas. Histopathology 2008;53:567-577
27.
Evans HL, Batsakis JG. Polymorphous low-grade adenocarcinoma of minor
salivary glands. A study of 14 cases of a distinctive neoplasm. Cancer
1984;53:935-942
28.
Evans HL, Luna MA. Polymorphous low-grade adenocarcinoma: a study of 40
cases with long-term follow up and an evaluation of the importance of papillary
areas. The American journal of surgical pathology 2000;24:1319-1328
29.
Eveson JW, Cawson RA. Salivary gland tumours. A review of 2410 cases with
particular reference to histological types, site, age and sex distribution. The
Journal of pathology 1985;146:51-58
30.
Fang FM, Li CF, Huang HY, et al. Overexpression of a chromatin remodeling
factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell
carcinoma. Am J Pathol 2011;178:2407-2415
31.
Fang FM, Li CF, Huang HY, et al. Overexpression of a chromatin remodeling
factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell
carcinoma. The American journal of pathology 2012;178:2407-2415
32.
Freedman PD, Lumerman H. Lobular carcinoma of intraoral minor salivary
gland origin. Report of twelve cases. Oral Surg Oral Med Oral Pathol
1983;56:157-166
33.
Goode RK, El-Naggar AK. Mucoepidermoid carcinoma. In: Barnes L, Eveson
JW, Reichart P, et al eds, Pathology and Genetics of Head and Neck
Tumours. Lyon: IARC Press; 2005:219-220
34.
Graveland AP, Golusinski PJ, Buijze M, et al. Loss of heterozygosity at 9p and
p53 immunopositivity in surgical margins predict local relapse in head and
neck squamous cell carcinoma. Int J Cancer 2011;128:1852-1859
35.
Grimm M. Prognostic value of clinicopathological parameters and outcome in
484 patients with oral squamous cell carcinoma: microvascular invasion (V+)
is an independent prognostic factor for OSCC. Clin Transl Oncol 2012;14:870880
36.
Gupta R, Singh S, Hedau S, et al. Spindle cell carcinoma of head and neck:
an immunohistochemical and molecular approach to its pathogenesis. J Clin
Pathol 2007;60:472-475
37.
Hsu DS, Chang SY, Liu CJ, et al. Identification of increased NBS1 expression
as a prognostic marker of squamous cell carcinoma of the oral cavity. Cancer
Sci 2010;101:1029-1037
38.
Huang SF, Li HF, Liao CT, et al. Association of HPV infections with second
primary tumors in early-staged oral cavity cancer. Oral Dis 2012;18:809-815
39.
Jaber MA. Intraoral minor salivary gland tumors: a review of 75 cases in a
Libyan population. Int J Oral Maxillofac Surg 2006;35:150-154
40.
Jane-Salas E, Lopez-Lopez J, Rosello-Llabres X, et al. Relationship between
oral cancer and implants: clinical cases and systematic literature review. Med
Oral Patol Oral Cir Bucal 2012;17:e23-28
41.
Johnson N, Franceschi S, Ferlay J, et al. Squamous cell carcinoma. In:
Barnes L, Eveson JW, Reichart P, et al eds, Pathology and Genetics of Head
and Neck Tumours. Lyon: IARC Press; 2005:168-175
42.
Jouzdani E, Yachouh J, Costes V, et al. Prognostic value of a three-grade
classification in primary epithelial parotid carcinoma: result of a histological
review from a 20-year experience of total parotidectomy with neck dissection
in a single institution. Eur J Cancer 2010;46:323-331
43.
Kearsley JH, Thomas S. Prognostic markers in cancers of the head and neck
region. Anti-cancer drugs 1993;4:419-429
44.
Kraus FT, Perezmesa C. Verrucous carcinoma. Clinical and pathologic study
of 105 cases involving oral cavity, larynx and genitalia. Cancer 1966;19:26-38
45.
Lajer CB, von Buchwald C. The role of human papillomavirus in head and
neck cancer. Apmis 2010;118:510-519
46.
Lee LA, Huang CG, Liao CT, et al. Human papillomavirus-16 infection in
advanced oral cavity cancer patients is related to an increased risk of distant
metastases and poor survival. PLoS One 2012;7:e40767
47.
Li Y, Bai S, Carroll W, et al. Validation of the Risk Model: High-Risk
Classification and Tumor Pattern of Invasion Predict Outcome for Patients with
Low-Stage Oral Cavity Squamous Cell Carcinoma. Head and neck pathology
2012
48.
Liao CT, Chang JT, Wang HM, et al. Survival in squamous cell carcinoma of
the oral cavity: differences between pT4 N0 and other stage IVA categories.
Cancer 2007;110:564-571
49.
Lin YT, Chuang HC, Chen CH, et al. Clinical significance of erythropoietin
receptor expression in oral squamous cell carcinoma. BMC Cancer
2012;12:194
50.
Lohavanichbutr P, Houck J, Doody DR, et al. Gene expression in uninvolved
oral mucosa of OSCC patients facilitates identification of markers predictive of
OSCC outcomes. PLoS One 2012;7:e46575
51.
Luna MA, Wenig BM. Polymorphous low-grade adenocarcinoma. In: Barnes L,
Eveson JW, Reichart P, et al eds, Pathology and Genetics of Head and Neck
Tumours. Lyon: IARC Press; 2005:223-224
52.
Mascolo M, Ilardi G, Romano MF, et al. Overexpression of chromatin
assembly factor-1 p60, poly(ADP-ribose) polymerase 1 and nestin predicts
metastasizing behaviour of oral cancer. Histopathology 2012;61:1089-1105
53.
McCoy JM, Waldron CA. Verrucous carcinoma of the oral cavity. A review of
forty-nine cases. Oral surgery, oral medicine, and oral pathology 1981;52:623629
54.
Melchers LJ, Schuuring E, van Dijk BA, et al. Tumour infiltration depth >/=4
mm is an indication for an elective neck dissection in pT1cN0 oral squamous
cell carcinoma. Oral Oncol 2012;48:337-342
55.
Mendez E, Houck JR, Doody DR, et al. A genetic expression profile
associated with oral cancer identifies a group of patients at high risk of poor
survival. Clin Cancer Res 2009;15:1353-1361
56.
Mendez E, Lohavanichbutr P, Fan W, et al. Can a metastatic gene expression
profile outperform tumor size as a predictor of occult lymph node metastasis in
oral cancer patients? Clin Cancer Res 2011;17:2466-2473
57.
Oliveira LR, Ribeiro-Silva A, Costa JP, et al. Prognostic factors and survival
analysis in a sample of oral squamous cell carcinoma patients. Oral surgery,
oral medicine, oral pathology, oral radiology, and endodontics 2008;106:685695
58.
Penner CR, Folpe AL, Budnick SD. C-kit expression distinguishes salivary
gland adenoid cystic carcinoma from polymorphous low-grade
adenocarcinoma. Mod Pathol 2002;15:687-691
59.
Perez-Ordonez B, Linkov I, Huvos AG. Polymorphous low-grade
adenocarcinoma of minor salivary glands: a study of 17 cases with emphasis
on cell differentiation. Histopathology 1998;32:521-529
60.
Rajendran R, Sugathan CK, Augustine J, et al. Ackerman's tumour (Verrucous
carcinoma) of the oral cavity: a histopathologic study of 426 cases. Singapore
Dent J 1989;14:48-53
61.
Rogers SN, Brown JS, Woolgar JA, et al. Survival following primary surgery
for oral cancer. Oral Oncol 2009;45:201-211
62.
Roland NJ, Caslin AW, Nash J, et al. Value of grading squamous cell
carcinoma of the head and neck. Head & neck 1992;14:224-229
63.
Romanach MJ, Azevedo RS, Carlos R, et al. Clinicopathological and
immunohistochemical features of oral spindle cell carcinoma. J Oral Pathol
Med 2010;39:335-341
64.
Schildhaus HU, Heukamp LC, Merkelbach-Bruse S, et al. Definition of a
fluorescence in-situ hybridization score identifies high- and low-level FGFR1
amplification types in squamous cell lung cancer. Mod Pathol 2012;25:14731480
65.
Schwarz S, Muller M, Ettl T, et al. Morphological heterogeneity of oral salivary
gland carcinomas: a clinicopathologic study of 41 cases with long term followup emphasizing the overlapping spectrum of adenoid cystic carcinoma and
polymorphous low-grade adenocarcinoma. Int J Clin Exp Pathol 2011;4:336348
66.
Schwarz S, Stiegler C, Muller M, et al. Salivary gland mucoepidermoid
carcinoma is a clinically, morphologically and genetically heterogeneous entity:
a clinicopathological study of 40 cases with emphasis on grading, histological
variants and presence of the t(11;19) translocation. Histopathology
2011;58:557-570
67.
Scully C, Bagan J. Oral squamous cell carcinoma: overview of current
understanding of aetiopathogenesis and clinical implications. Oral Dis
2009;15:388-399
68.
Seethala RR, Hunt JL, Baloch ZW, et al. Adenoid cystic carcinoma with highgrade transformation: a report of 11 cases and a review of the literature. The
American journal of surgical pathology 2007;31:1683-1694
69.
Skalova A, Sima R, Kaspirkova-Nemcova J, et al. Cribriform adenocarcinoma
of minor salivary gland origin principally affecting the tongue: characterization
of new entity. The American journal of surgical pathology 2011;35:1168-1176
70.
Toida M, Shimokawa K, Makita H, et al. Intraoral minor salivary gland tumors:
a clinicopathological study of 82 cases. Int J Oral Maxillofac Surg
2005;34:528-532
71.
Woolgar JA, Rogers SN, Lowe D, et al. Cervical lymph node metastasis in oral
cancer: the importance of even microscopic extracapsular spread. Oral Oncol
2003;39:130-137
72.
Yih WY, Kratochvil FJ, Stewart JC. Intraoral minor salivary gland neoplasms:
review of 213 cases. J Oral Maxillofac Surg 2005;63:805-810
73.
Zhao D, Xu QG, Chen XM, et al. Human papillomavirus as an independent
predictor in oral squamous cell cancer. Int J Oral Sci 2009;1:119-125